Apoptosis susceptibility and cell-cycle distribution in cells in from myelodysplastic syndrome patients: Modulatory in-vitro effects of G-CSF and interferon-α

Leukemia and Lymphoma

Volumn 45, Issue 7, 2004, Pages 1437-1443

  Ricciardi, Maria R ^a   Petrucci, Maria T ^a   Gregorj, Chiara ^a   Martini, Vincenza ^a   Levi, Anna ^a   De Cuia, Maria R ^a   Latagliata, Roberto ^a   Petti, Maria C ^b   Mandelli, Franco ^a   Foa, Robin ^a   Tafuri, Agostino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Apoptosis; Cell cycle; G CSF; IFN ; Myelodysplastic syndromes

Indexed keywords

ALPHA INTERFERON; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; LYMPHOBLAST INTERFERON;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL ISOLATION; CELL KINETICS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REGULATORY MECHANISM;

ADULT; AGED; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; APOPTOSIS; BONE MARROW CELLS; CELL CYCLE; CELLS, CULTURED; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED;

EID: 2542636360     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001657335     Document Type: Article

References (31)

1. Parker, E.J. and Mufti, G.J. (1998a) "Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes", British Journal of Haematology, 101, 220-230.
2. Yoshida, Y. (1993) "Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndromes", Leukemia, 7, 144-146.
3. Raza, A., Gezer, S., Mundle, S., Gao, X-Z., Alvi, S., Borok, R., et al. (1995) "Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndrome", Blood, 86, 268-276.
4. Rajapaksa, R., Ginzton, N., Rott, L.S. and Greenberg, P.L. (1996) "Altered oncoprotein expression and apoptosis in myelodysplastic syndromes marrow cells", Blood, 88, 4275-4287.
5. Bogdanovic, A.D., Trpinac, D.P., Jankovic, G.M., Bumbasirevic, V.Z., Obradovic, M. and Colovic, M.D. (1997) " Incidence and role of apoptosis in myelodysplastic syndromes: morphological and ultrastructural assessment", Leukemia, 11, 656-659.
6. Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., et al. (1997) "Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes", Leukemia, 11, 839-845.
7. Shetty, V., Huissaini, S., Broady-Robinson, L.T., Allampallam, K., Mundle, S., Borok, R., et al. (2000) " Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates", Blood, 96, 1388-1392.
8. Parker, E.J., Mufti, G.J., Rasool, F., Mijovic, A., Devereux, S. and Pagliuca, A. (2000) "The role of apoptosis, proliferation, and bcl-2 related proteins in the myelodysplastic syndrome and acute myeloid leukemia secondary to MDS", Blood, 96, 3932-3938.
9. Yang, E. and Korsmeyer, S.J. (1996) "Molecular thanatopsis: a discourse on the Bcl-2 family and cell death", Blood, 88, 386-401.
10. Parker, E.J., Fishloch, K.L., Mijovic, A., Czepulkowski, B., Pagliuca, A. and Mufti, G.J. (1998b) " 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2 related proteins", British Journal of Haematology, 103, 1075-1082.
11. Negrin, R.S., Haeuber, D.H., Nagler, A., Olds, L.C., Donlon, T., Souza, L. et al. (1989) "Treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. A phase I-II trial", Annals of Internal Medicine, 110, 976-984.
12. Negrin, R.S., Stein, R., Vardiman, J., Doherty, K., Cornwell, J., Krantz, S. et al. (1993) "Treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor in combination with erythropoietin", Blood, 82, 737-743.
13. Hellstrom-Lindberg, E., Birgegard, G., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., et al. (1993) "A combination of granulocyte colony stimulating factor and erythropoietin may synergistically improve the anemia in patients with myelodysplastic syndromes", Leukemia and Lymphoma, 11, 221-228.
14. Hellstrom-Lindberg, E., Negrin, R.S., Stein, R., Krantz, S., Lindberg, G., Vardiman, J., et al. (1997) "Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model", British Journal of Haematology, 99, 344-351.
15. Carlo-Stella, C., Cazzola, M., Ganser, A., Bergamaschi, G., Meloni, F., Pedrazzoli, P., et al. (1988) "Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syndromes", Leukemia, 2, 55-59.
16. Galvani, D., Nethersell, A. and Bottomley, J. (1987) "Treatment of myelodysplasia with alpha-interferon", Leukemia, 1, 786-787.
17. Holcombe, R.F. (1993) "Mini-dose interferon alpha-2a in the treatment of myelodysplasia", Leukemia, 7, 192-195.
18. Petti, M.C., Latagliata, R., Avvisati, R., Aloe Spiriti, M.A., Montefusco, E., Spadea, A., et al. (1996) "Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferon", British Journal of Haematology, 95, 364-367.
19. Mandelli, F., Arcese, W. and Avvisati, G. (1994) "The interferons in hematological malignancies", Bailliere's Clinical Haemotology, 7, 91-113.
20. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. et al. (1982) "Proposal for the classification of the myelodysplastic syndromes", British Journal of Haematology, 51, 189-199.
21. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, 2079-2088.
22. Tafuri, A., Lemoli, R.M., Chen, R., Gulati, S.C., Clarkson, B.D. and Andreeff, M. (1994) "Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs", Leukemia, 8, 749-757.
23. Ricciardi, M.R., Petrucci, M.T., Gregorj, C., Ariola, C., Lemoli, R.M., Fogli, M., et al. (2001) "Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia", British Journal of Haematology, 113, 391-399.
24. Tafuri, A., Lemoli, R.M., Petrucci, M.T., Ricciardi, M.R., Fogli, M., Bonsi, L., et al. (1999) "Thrombopoietin and interleukin-11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells", Experimental Hematology, 27, 1255-1263.
25. Huh, Y.O., Estey, E., Giles, F., Kantarjian, H., Freireich, E. and Albitar, M. (2000) "More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia", Leukemia, 16, 2249-2252.
26. Tafuri, A. and Andreeff, M. (1990) "Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro", Leukemia, 4, 826-834.
27. Selleri, C., Sato, T., Anderson, S., Young, N.S. and Maciejewski, P.J. (1995) "Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death", Journal of Cellular Physiology, 165, 538-546.
28. Maciejewski, P.J., Selleri, C., Anderson, S. and Young, N.S. (1995) "Fas antigen expression on CD34 + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro." Blood, 85, 3193-3190.
29. Santini, V. and Rossi Ferrini, P. (1998) "Differentiation therapy of myelodysplastic syndromes: fact or fiction?", British Journal of Haematology, 102, 1124-1138.
30. Bouscary, D., Chen, Y.L., Guesnu, M., Picard, F., Viguier, F., Lacombe, C., et al. (2000). "Activity of caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro", Experimental Hematology, 28, 784-791.
31. Gersuk, G.M., Beckham C., Loken, M.R., Kiener, P., Anderson, J.E., Farrand, A., et al. (1998) "A role for tumor necrosis factor-alpha Fas and Fas-ligand in marrow failure associated with myelodysplastic syndromes", British Journal of Haematology, 103, 176-188.